Search clinical trials for: Bortezomib Injection
Total 10672 results
-
National Cancer Institute (NCI)CompletedNon-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung CancerUnited States
-
Janssen-Cilag B.V.CompletedMultiple Myeloma | Hematological NeoplasmsNetherlands
-
Mayo ClinicNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium Pharmaceuticals, Inc.CompletedHead and Neck Cancer | Central Nervous System Neoplasms | Brain Cancer | Cervix CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; Millennium...CompletedLymphoplasmacytic Lymphoma | Waldenstrom's MacroglobulinemiaUnited States
-
Vejle HospitalOdense University HospitalCompletedMultiple MyelomaDenmark
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Zhongnan HospitalRecruitingAcute Myeloid Leukemia | BortezomibChina
-
Jonsson Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.Completed
-
Dana-Farber Cancer InstituteMemorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Beth... and other collaboratorsCompleted
-
Shanghai Jiao Tong University School of MedicineTerminated
-
Janssen Korea, Ltd., KoreaCompletedMultiple Myeloma
-
Janssen Korea, Ltd., KoreaCompletedMultiple MyelomaKorea, Republic of
-
International Extranodal Lymphoma Study Group (IELSG)CompletedLymphoma, Mucosa-Associated Lymphoid TissueSwitzerland
-
Rehabilitace MUDr. Hasan Mezian s.r.o.UnknownCarpal Tunnel SyndromeCzechia
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
Genentech, Inc.Seagen Inc.Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.Active, not recruitingMantle Cell LymphomaUnited States
-
Janssen-Cilag International NVCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham and...TerminatedMyelodysplastic SyndromeUnited States
-
University of ArkansasMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
University of LeipzigCelgene CorporationRecruitingMyelodysplastic Syndromes | AnemiaGermany
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Second Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory Multiple MyelomaChina
-
European Organisation for Research and Treatment...CompletedMalignant MesotheliomaUnited Kingdom
-
OncotherapeuticsMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
Vivozon, Inc.CompletedPost-Operative PainKorea, Republic of
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedColorectal CancerCanada
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Shandong UniversityThe Affiliated Hospital of Qingdao University; Yantai Yuhuangding HospitalUnknownPurpura, Thrombocytopenic, Idiopathic | Immune ThrombocytopeniaChina
-
Hackensack Meridian HealthGenentech, Inc.TerminatedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMultiple MyelomaUnited States
-
Swiss Group for Clinical Cancer ResearchEuropean Mantle Cell Lymphoma NetworkTerminatedMantle Cell LymphomaItaly, Germany, Switzerland
-
National Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Promyelocytic Leukemia (M3) | Previously Treated Myelodysplastic Syndromes | Recurrent Adult Acute Lymphoblastic Leukemia | Relapsing Chronic Myelogenous Leukemia | Refractory Anemia With Excess Blasts | Blastic Phase Chronic Myelogenous Leukemia and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Indiana UniversityCompletedPancreatic Cancer | Chronic PancreatitisUnited States
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompleted
-
Cancer Trials IrelandCompletedMalignant MesotheliomaUnited Kingdom, Ireland, Belgium, Netherlands
-
University of BolognaJanssen-Cilag Ltd.Unknown
-
University of Kansas Medical CenterMillennium Pharmaceuticals, Inc.CompletedAutologous Transplant | Malignant Lymphoma, Stem Cell TypeUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedWaldenstrom MacroglobulinemiaFrance
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, United Kingdom, Canada, Israel, France, Austria, Belgium, Germany, Ireland, Italy, Netherlands, Spain, Sweden
-
Prof. Dr. Clemens SchmittCharite University, Berlin, Germany; Janssen-Cilag Ltd.Active, not recruitingDiffuse Large B Cell LymphomaGermany
-
Virginia Commonwealth UniversityCompletedMelanoma | Soft Tissue Sarcoma | Parathyroid Carcinoma | Small Cell Carcinoma of the Lung | Carcinoid TumorsUnited States
-
Maisonneuve-Rosemont HospitalCompletedMultiple Myeloma | High-Risk CancerCanada
-
National Cancer Institute (NCI)CompletedSquamous Cell CarcinomaUnited States